PolicyX.com
InsurTech · Insurance Aggregator
Valuation
₹500 – 900 Cr
Unlisted Price
₹60
52-Week Range
₹45 – ₹80
Expected IPO
TBD
About
India's leading online insurance comparison and purchase platform; profitable InsurTech with growing share of the fast-expanding digital insurance distribution market.
Key Highlight
Profitable online insurer aggregator; +5.3% recent price gain
Financial Ratios & Metrics
Detailed financial data is not yet available for this company.
Financial disclosures for unlisted entities are limited until DRHP filing.
Share Information
IPO Details
Tags
Latest News
Auto-updated · Google NewsNews sourced from Google News RSS. Headlines link to original publishers. The Finance Network does not own this content.
Frequently Asked Questions
What is the current unlisted share price of PolicyX.com?▾
The current indicative unlisted share price of PolicyX.com is ₹60, with a 52-week range of ₹45 – ₹80. This is a grey market price and not exchange-regulated.
When is the PolicyX.com IPO expected?▾
PolicyX.com has not announced a confirmed IPO timeline yet. Current IPO status is: Not Filed.
What is the valuation of PolicyX.com?▾
PolicyX.com is valued at approximately ₹500 – 900 Cr ($60–108M). This is a pre-IPO estimate based on grey market data and analyst reports.
What sector does PolicyX.com operate in?▾
PolicyX.com operates in the InsurTech — specifically Insurance Aggregator sector. Key highlight: Profitable online insurer aggregator; +5.3% recent price gain
Is PolicyX.com a good pre-IPO investment?▾
PolicyX.com is tracked on The Finance Network as a pre-IPO research subject. Key data: valuation ₹500 – 900 Cr, IPO status Not Filed, expected listing TBD. This is not investment advice — always consult a SEBI-registered adviser.
Disclaimer: All data is sourced from publicly available filings, analyst reports, and grey market platforms. Unlisted share prices are indicative and not exchange-regulated. Financial ratios for unlisted companies are estimated and may differ from audited figures. This is not investment advice. Read full disclaimer →
